Cytokines in cancer immunotherapy. 2011

Sylvia Lee, and Kim Margolin
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98195, USA. kmargoli@seattlecca.org.

Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines.

UI MeSH Term Description Entries

Related Publications

Sylvia Lee, and Kim Margolin
December 2018, Cold Spring Harbor perspectives in biology,
Sylvia Lee, and Kim Margolin
May 1992, Nederlands tijdschrift voor geneeskunde,
Sylvia Lee, and Kim Margolin
January 2019, British journal of cancer,
Sylvia Lee, and Kim Margolin
April 1992, Nederlands tijdschrift voor geneeskunde,
Sylvia Lee, and Kim Margolin
May 2000, Immunological investigations,
Sylvia Lee, and Kim Margolin
December 2004, Immunological reviews,
Sylvia Lee, and Kim Margolin
January 2000, Immunologic research,
Sylvia Lee, and Kim Margolin
January 2021, Drug design, development and therapy,
Sylvia Lee, and Kim Margolin
April 2021, Antibody therapeutics,
Sylvia Lee, and Kim Margolin
January 2001, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Copied contents to your clipboard!